ACET Adicet Bio Inc

Price (delayed)

$12.23

Market cap

$388.67M

P/E Ratio

N/A

Dividend/share

N/A

EPS

-$5.01

Enterprise value

$321.46M

Sector: Healthcare
Industry: Biotechnology

Highlights

ACET's EPS has surged by 62% year-on-year and by 39% since the previous quarter
The quick ratio has increased by 18% from the previous quarter
The company's net income fell by 30% YoY and by 8% QoQ
Adicet Bio's equity has decreased by 6% QoQ

Key stats

What are the main financial stats of ACET
Market
Shares outstanding
31.78M
Market cap
$388.67M
Enterprise value
$321.46M
Valuations
Price to earnings (P/E)
N/A
Price to book (P/B)
2.18
Price to sales (P/S)
5
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
17.96
Earnings
Revenue
$17.9M
EBIT
-$39.36M
EBITDA
-$37.41M
Free cash flow
-$42.54M
Per share
EPS
-$5.01
Free cash flow per share
-$5.81
Book value per share
$5.6
Revenue per share
$2.45
TBVPS
$18.27
Balance sheet
Total assets
$153.84M
Total liabilities
$44.01M
Debt
$21.64M
Equity
$109.83M
Working capital
$77.86M
Liquidity
Debt to equity
0.2
Current ratio
4.46
Quick ratio
4.41
Net debt/EBITDA
1.8
Margins
EBITDA margin
-208.9%
Gross margin
100%
Net margin
-204.9%
Operating margin
-218.9%
Efficiency
Return on assets
-32.1%
Return on equity
-39.3%
Return on invested capital
-231.7%
Return on capital employed
-30%
Return on sales
-219.8%
Dividend
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A

ACET stock price

How has the Adicet Bio stock price performed over time
Intraday
-0.08%
1 week
-4.75%
1 month
-15.89%
1 year
936.44%
YTD
-12.95%
QTD
-6.5%

Financial performance

How have Adicet Bio's revenue and profit performed over time
Revenue
$17.9M
Gross profit
$17.9M
Operating income
-$39.19M
Net income
-$36.68M
Gross margin
100%
Net margin
-204.9%
Adicet Bio's net margin has surged by 93% YoY and by 70% QoQ
Adicet Bio's operating margin has soared by 93% YoY and by 68% from the previous quarter
The company's net income fell by 30% YoY and by 8% QoQ
ACET's operating income is down by 25% YoY and by 16% from the previous quarter

Growth

What is Adicet Bio's growth rate over time

Valuation

What is Adicet Bio stock price valuation
P/E
N/A
P/B
2.18
P/S
5
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
17.96
ACET's EPS has surged by 62% year-on-year and by 39% since the previous quarter
ACET's price to book (P/B) is 82% higher than its last 4 quarters average of 1.2
Adicet Bio's equity has decreased by 6% QoQ

Efficiency

How efficient is Adicet Bio business performance
ACET's return on sales has surged by 92% year-on-year and by 68% since the previous quarter
ACET's ROE is up by 41% QoQ but it is down by 11% YoY
Adicet Bio's return on assets has decreased by 38% YoY but it has increased by 9% QoQ
Adicet Bio's ROIC has decreased by 29% from the previous quarter

Dividends

What is ACET's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for ACET.

Financial health

How did Adicet Bio financials performed over time
The company's total assets has surged by 89% YoY and by 2.3% QoQ
Adicet Bio's total liabilities has soared by 58% YoY and by 31% from the previous quarter
Adicet Bio's debt is 80% lower than its equity
Adicet Bio's equity has decreased by 6% QoQ

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.